Emerging roles of Sirtuins in alleviating alcoholic liver Disease: a comprehensive review
Saad, Zagazig University, Egypt Harianingsih Harianingsih, Universitas Negeri Semarang, Indonesia Prakorn Ramakul, Silpakorn University, Thailand Updates Copyright 2025 Perez, Martinez-Correa, Parada-Alfonso, Surez Montenegro, Ballesteros-Vivas, lvarez-Rivera, Cifuentes and Ibez
158-160 In 2014, suvorexant (Belsomra) became the first drug in this class to receive FDA approval for the treatment of insomnia resulting from difficulty initiating or maintaining sleep
The symptoms of LBD include fluctuations in alertness, visual hallucinations, movement difficulties similar to Parkinsons disease, sleep disturbances, and cognitive decline affecting attention and executive functions